Ergoteles’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Ergoteles’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,193	Closed	-$161K	–	2196
2022 Q2	$161K	Buy	+3,193	New	+$238K	﹤0.01%	1399

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Ergoteles's AMPE Position: Q3 2022 in Review

Ergoteles sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 3,193 shares — an estimated $161K sold.

Ergoteles first reported a position in AMPE in Q2 2022 and held it in 1 quarter. The position peaked at $161K in Q2 2022. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

Ergoteles reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 3,193 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $161K.
Ergoteles first reported a position in Ampio Pharmaceuticals Inc. in Q2 2022 and held it in 1 quarter.
Ergoteles's Ampio Pharmaceuticals Inc. position peaked at $161K in Q2 2022.
95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.